Isomark® LLC. Announces Partnership With Height Family Christian Business For Human Screening Application

Today in Madison Wisconsin, Isomark LLC announced a partnership with Height Family-Christian Business to develop the first and only technology in development today able to identify pre-symptomatic infections. This disruptive breath technology is able to detect in less than one minute with >90% accuracy whether a person has an infection within 4-6 hours of onset. The Isomark Canary™ in recent clinical trials in adult and pediatric intensive care units (ICUs), measured the breath Iso-number and accurately predicted the onset of infection up to 48 hours before all clinical best practices. The Isomark test is a simple, non-invasive, inexpensive solution for…
Read More

Textile producer offers innovative way to reduce hospital-acquired infections

A veteran of the pharmaceutical industry and a biotechnology entrepreneur has a new venture — microbe-resistant textiles for hospitals. Lisa Grimes, the CEO, says PurThread Technologies is taking a different approach than most textile companies in this sector. Instead of treating the clothing and fabric after they are produced, it adds the protective coating at the beginning of the process with the thread. READ FULL STORY
Read More

Study challenges basic assumptions about C. diff transmission

A new study contradicts widely held assumptions about how Clostridium difficile infection occurs, which may lead long-term care providers to step up control measures. Most C. diff infection control protocols are based on a belief that symptomatic patients in healthcare settings are the primary sources of transmission. However, researchers in the United Kingdom have concluded this may not be true, based on genetic analysis of samples obtained from 1,223 people in Oxfordshire between 2007-2011. READ FULL STORY
Read More